Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with acute and chronic heart failure. The therapeutic principle of the device is aimed at addressing a pathophysiological core element of acute heart failure - renal venous congestion and its deleterious effects on renal and cardiac function.